Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017444
Filing Date
2023-05-04
Accepted
2023-05-04 06:49:15
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-20230331.htm   iXBRL 10-Q 2010524
2 EX-10.2 krtx-ex10_2.htm EX-10 129970
3 EX-31.1 krtx-ex31_1.htm EX-31 17602
4 EX-31.2 krtx-ex31_2.htm EX-31 17760
5 EX-32.1 krtx-ex32_1.htm EX-32 17873
  Complete submission text file 0000950170-23-017444.txt   8303525

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20230331.xsd EX-101.SCH 62093
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krtx-20230331_cal.xml EX-101.CAL 59521
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krtx-20230331_def.xml EX-101.DEF 195221
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20230331_lab.xml EX-101.LAB 461506
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20230331_pre.xml EX-101.PRE 332469
56 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20230331_htm.xml XML 1622602
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 23886326
SIC: 2834 Pharmaceutical Preparations